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Abstract Human embryonic stem cells (hESCs) have great
potential for regenerative medicine as they have self-
regenerative and pluripotent properties. Feeder cells or their
conditioned medium are required for the maintenance of
hESC in the undifferentiated state. Feeder cells have been
postulated to produce growth factors and extracellular mole-
cules for maintaining hESC in culture. The present study has
aimed at identifying these molecules. The gene expression of
supportive feeder cells, namely human foreskin fibroblast
(hFF-1) and non-supportive human lung fibroblast (WI-38)
was analyzed by microarray and 445 genes were found to be
differentially expressed. Gene ontology analysis showed that
20.9% and 15.5% of the products of these genes belonged to
the extracellular region and regulation of transcription activity,
respectively. After validation of selected differentially
expressed genes in both human and mouse feeder cells, trans-
forming growth factor α (TGFα) was chosen for functional
study. The results demonstrated that knockdown or protein
neutralization of TGFα in hFF-1 led to increased expression
of early differentiation markers and lower attachment rates of
hESC. More importantly, TGFα maintained pluripotent gene
expression levels, attachment rates and pluripotency by the in
vitro differentiation of H9 under non-supportive conditions.
TGFα treatment activated the p44/42MAPK pathway but not
the PI3K/Akt pathway. In addition, TGFα treatment increased
the expression of pluripotent markers, NANOG and SSEA-3
but had no effects on the proliferation of hESCs. This study of
the functional role of TGFα provides insights for the devel-
opment of clinical grade hESCs for therapeutic applications.
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Abbreviations
bFGF Basic fibroblast growth factor
EB Embryoid body
ECM Extracellular matrix
hESC Human embryonic stem cell
hFF-1 Human foreskin fibroblast
LIF Leukemia inhibitory factor
MAPK Mitogen-activated protein kinase
MEF Mouse embryonic fibroblast
mES Mouse embryonic stem cells
PCNA Proliferating cell nuclear antigen
PI3-K Phosphoinositide 3-kinase
TGFA Transforming growth factor α
TGFΒ Transforming growth factor β
WI-38 Human lung fibroblast
Introduction
Human embryonic stem cells (hESCs) are derived from the
inner cell mass of blastocysts. Their pluripotent and self-
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renewal properties enable their potential use in regenerative
medicine (D’Amour and Gage 2000). Human ESCs were
first successfully cultured on mouse embryonic fibroblast
(MEF) feeder cells (Reubinoff et al. 2000; Thomson et al.
1998). To avoid possible xenogeneic contamination with the
use of mouse feeder cells (Martin et al. 2005; Stacey et
al. 2006), human feeder cells such as foreskin fibro-
blasts (Hovatta et al. 2003) and immortalized fibroblasts
derived from hESCs (Xu et al. 2004) were subsequently
used. However, the use of human feeder cells still has
the problem of viral transmission and is labor intensive
(Stacey et al. 2006). Therefore, feeder-free systems have
been developed (Amit et al. 2004; Draper et al. 2004;
Xu et al. 2001) but some of these systems cause chro-
mosome instabilities and impair the cellular behavior of
hESCs (Catalina et al. 2008; Maitra et al. 2005).
Feeder cells secrete growth factors for the growth and
maintenance of hESCs (Amit et al. 2000; Greber et al.
2007; Xu et al. 2005). One of the growth factors pro-
duced is basic fibroblast growth factor (bFGF). Its sup-
plementation to the culture medium is important for the
self-renewal of hESCs (Xu et al. 2005). Another feeder-
derived growth factor, transforming growth factor beta
(TGFβ), prolongs the undifferentiated growth of hESCs
when it is used together with leukemia inhibitory factor
(LIF) and bFGF (Amit et al. 2004). bFGF has been
reported to modulate TGFβ signaling in sustaining the
pluripotency of hESCs (Greber et al. 2007).
One way to improve the feeder-free system is to identify
feeder-cell-derived growth factors that are important for
supporting hESCs in vitro. In this study, we have aimed at
identifying these molecules by comparing the gene expres-
sion patterns of two human feeder cells, namely hFF-1 and
WI-38, by using a microarray approach; the former (Hovatta
et al. 2003) but not the latter cell type supports hESC culture
(Richards et al. 2003). We reason that the superior abilities
of hFF-1 over WI-38 are attributable to the genes that are
differentially expressed in the two cell types.
Materials and methods
Feeder cell culture
Mouse embryonic fibroblast cell lines (STO and NIH/3T3),
human foreskin fibroblast (hFF-1) and human lung fibro-
blasts (WI-38) were obtained from American Type Culture
Collection (ATCC; Manassas, Va., USA). The feeder cells
were cultured in high-glucose Dulbecco’s modified Eagle’s
medium (DMEM; Gibco, Invitrogen, Calif., USA) supple-
mented with 15% inactivated fetal bovine serum (FBS;
Gibco), 1.5 g/l sodium bicarbonate (Sigma-Aldrich, St.
Louis, USA), L-glutamine (Gibco) and 1% penicillin-
streptomycin (Gibco). The feeder cells were passaged every
4–7 days.
ESC culture
hESCs, namely H9 and BG01V, were obtained from the
National Stem Cell Bank (NSCB; WiCell Research Institute,
USA) and American Type Culture Collection (ATCC),
respectively. In the feeder system, hESCs were cultured
on mitomycin-C (Invitrogen, Calif., USA)-treated human
feeder layers (hFF-1 or WI-38) seeded on 0.1% gelatin
(Sigma-Aldrich)-coated plates. The cells were main-
tained in KnockOut DMEM (KO-DMEM; Gibco) sup-
plemented with 15% Knockout Serum Replacer (Gibco),
0.1 mM MEM non-essential amino acids (Gibco),
2 mM L-glutamine (Gibco), 0.1 mM 2-mercaptoethanol
(Invitrogen) and 20 ng/ml bFGF (Invitrogen). For feeder
experiments, H9 was manually dissected into fragments
and cultured on human feeder layers. In the feeder-free
system, hESCs were cultured on Geltrex (Invitrogen)-
coated plates with StemPro-SFM (serum- and feeder-free
medium; Invitrogen) supplemented with 0.1 mM
2-mercaptoethanol (Invitrogen) and 10 ng/ml bFGF
(Invitrogen) with or without TGFα (R&D Systems,
Minneapolis, Minn., USA) treatment. The culture
medium was replaced every 48 h and the hESCs were
passaged every 6 days.
Collection of conditioned medium from human feeder cells
The conditioned medium (CM) was collected from human
feeder cells (hFF-1 and WI-38) as described (McElroy and
Reijo Pera 2008) with some modifications. Mitomycin-C-
treated human feeder cells (hFF-1 or WI-38) were seeded at
a density of 0.02×106 cells/cm2. After being cultured in
feeder medium for 24 h, the feeder cells were washed with
ESC medium in the feeder system as described and further
cultured in the medium at a volume of 0.3 ml/cm2 for 24 h.
The CM were then collected and filtered through a 0.45-μm
filter to remove cell debris and frozen at −20 °C for later use.
Alkaline phosphatase activity assay
The hESC colonies were first fixed with 4% formaldehyde
(freshly prepared from paraformaldehyde) for 1–2 min at
room temperature. The alkaline phosphatase activity was
determined by the ES Cell Characterization Kit (Chemicon,
Millipore, Mass., USA) following the manufacturer’s pro-
tocol. Briefly, Fast Red Violet (0.8 g/l) was mixed with
Naphthol AS-BI phosphate solution (4 mg/ml) and water
in a ratio of 2:1:1 to prepare the Naphthol/Fast Red Violet
solution. Fixed hESC colonies were incubated with
Naphthol/Fast Red Violet Solution in the dark for
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15 min. Colonies stained red were positive for alkaline
phosphatase activity, whereas colorless colonies were
considered negative for enzyme activity.
Embryoid body formation
Following hESCs culture under various conditions, they
were enzymatically digested with Accutase (Sigma-
Aldrich). Embryoid body (EB) was formed by aggregating
25,000 cells in each well of 96-well ultra-low attachment
plate (Corning, Sigma-Aldrich) by centrifugation at 300g
for 5 min. The cells were maintained in high-glucose
DMEM supplemented with 20% inactivated FBS to induce
the formation of suspended EB. After 4 days of suspension
culture, EBs were transferred to 0.1% gelatin-coated plates
for attachment growth.
Small interfering RNA transfection and antibody treatment
Small interfering RNAs (si-RNAs; Santa Cruz, Calif., USA)
were used to down-regulate TGFA expression. hFF-1 was
seeded at 0.025×106 cells/cm2 and cultured for 24 h. The
medium was replaced with Opti-MEM medium (Invitrogen)
and the cells were transfected with 100 nM si-RNAs
(scramble si-RNA and TGFA si-RNA; Santa Cruz) with
lipofectamine 2000 (Invitrogen) for 4 h. The cells were used
for ESC culture as described. Blocking of function was also
performed by TGFα antibody neutralization. Mitomycin-C-
inactivated hFF-1 was treated with goat serum antibody
reacting with TGFα (0.8 ng/ml; R&D Systems) 1 h prior to
the seeding of H9. Purified goat normal IgG (0.8 ng/ml;
Zymed, Invitrogen) was used as a control.
Gene expression profiling of human feeder cells
Mitotically inactivated hFF-1 and WI-38 were cultured on
10-cm culture plates for 1 day before trypsinization with
0.05% trypsin-EDTA (Invitrogen). Total RNAwas extracted
from hFF-1 and WI-38 (n03) samples from various passages
by the RNeasy Mini Kit (Qiagen, Crawley, Sussex, UK).
The qualities of the extracted RNA were examined by an
Agilent 2100 bioanalyzer (Waldboronn, Germany) and
1 μg total RNA from each sample was used for gene
profiling by the GeneChip system (Human Genome U133
Plus 2.0 microarray, Affymetrix, Santa Clara, Calif., USA),
which was composed of more than 54,000 probes targeted at
over 47,000 human transcripts and variants.
Reverse transcription and real-time quantitative polymerase
chain reaction
Total RNAs from hFF-1, WI-38, STO and NIH/3T3 were
extracted by the mirVana PARIS Kit (Ambion, Austin,
USA) and reverse-transcribed by TaqMan Reverse Tran-
scription Reagents (Applied Biosystems, Foster City, Calif.,
USA). Relative quantification of mRNA was performed by
real-time quantitative PCR (qPCR) in a 7500 Real-Time
PCR System (Applied Biosystems) and normalized with
endogenous 18S ribosomal RNA by using the 2−ΔΔCT meth-
od. The data were analyzed by the manufacturer’s software
(Applied Biosystems).
Western blot analysis
Cells were lysed with the cell disruption buffer of the
mirVana PARIS Kit (Ambion) supplemented with protease
and phosphatase inhibitors (Calbiochem, Darmstadt, Ger-
many). Equal amounts of protein were heat-inactivated,
resolved in 10% or 12% polyacrylamide gels and trans-
ferred to polyvinylidene fluoride membrane for Western blot
analysis with antibodies against cell-signaling molecules
(Cell Signaling, Mass., USA): phosphotyrosine, phospho-
p44/42 mitogen-activated protein kinase (p44/42 MAPK),
phospho-AKT (Ser473), phospho-AKT (Thr308), AKT,
NANOG (R&D, Minn., USA) and proliferating cell nuclear
antigen (PCNA; Dako, Glostrup, Denmark), or β-ACTIN
(Sigma-Aldrich) for normalization.
Flow cytometric analysis
H9 was trypsinized and resuspended in phosphate-buffered
saline (PBS) at 106 cells/ml. For cell-surface staining of
stage-specific embryonic antigen-3 (SSEA-3; BD Bioscien-
ces, San Jose, Calif., USA), H9 were fixed in 4% formalde-
hyde (freshly prepared from paraformaldehyde), followed
by incubation with phycoerythrin-conjugated anti-SSEA-3
antibody. For nuclear staining of the proliferation marker,
H9 was first incubated with 10 μM BrdU for 1 h prior to
fixation in methanol. The cells were then incubated succes-
sively with sheep serum antibodies reacting with BrdU
(Abcam, Cambridge, Mass., USA) and fluorescein-
isothiocyanate-conjugated rabbit serum antibodies reacting
with sheep-IgG (Zymed, Invitrogen). The percentage of
fluorescently labeled cells was analyzed by flow cytometry
(FACSCanto II, BD Biosciences) by using the software
WinMDI 2.9 (The Scripps Research Institute, Calif., USA).
Fluorescent immunocytochemical staining of pluripotent
and differentiation markers
The hESC colonies or EB were washed with PBS and fixed
with 4% formaldehyde (freshly prepared from paraformal-
deyhde), followed by permeabilization with 0.1% Triton.
Normal goat or rabbit serum was used for blocking prior
to incubation with the appropriate primary antibody diluted
in blocking solution at 4°C overnight. Subsequently, the
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cells were incubated with the corresponding secondary an-
tibody for 1 h at room temperature in the dark. The nuclei of
the cells were stained with propidium iodide or 4′-6-diami-
dino-2-phenylindole. The fluorescent images were observed
under an inverted fluorescence microscope (Nikon, Japan)
equipped with a digital camera (Sensys, Photometrics,
Tucson, USA) or a confocal microscope (LSM 700,
Carl Zeiss, Oberkochen, Germany). The antibodies used
were against SSEA-4, TRA-1-60, TRA-1-81 (Chemion,
Millipore, Mass., USA), Nanog (R&D), OCT4 (Santa
Cruz), or KRT-18 (Abcam).
Statistical analysis
Data were analyzed and plotted by using SigmaPlot soft-
ware (Aspire Software International, Leesburg, Va., USA).
One-way analysis of variance (ANOVA) followed by the
Student-Newman Keuls method/Rank Sum Test were used
to compare the results. A P value<0.05 was considered to be
statistically significant.
Results
hFF-1 but not WI-38 supported the culture of hESC
The two hESC lines used in this study, H9 and BG01V, were
first characterized. Positive alkaline phosphatase activities
were found in both H9 and BG01V (Suppl. Fig. 1a). Immu-
nocytochemistry indicated that the colonies stained positively
for pluripotent markers (NANOG, OCT4, TRA-1-60, TRA-1-
81, SSEA-4) and gap junction molecules (CX-43), whereas
the expression of the early differentiation marker KRT18
(Cauffman et al. 2009) was minimal (Suppl. Fig. 1b). Upon
in-vitro differentiation of H9 and BG01V by the formation of
EB, positive immunoreactivities of the three germ layer
markers (mesoderm: muscle-actin; ectoderm: tubulin-βIII;
endoderm: α-fetoprotein) were present in the cells, indicating
that they were pluripotent under our culture conditions
(Suppl. Fig. 1c).
Previously, hFF-1 (Hovatta et al. 2003) but not WI-38
(Dravid et al. 2005) was reported to support the undifferen-
tiated growth of H9 (hESC used for the functional study in
the present study). Our data also demonstrated that H9
grown on hFF-1 had higher pluripotent marker expressions
(NANOG and OCT4) and lower differentiation marker ex-
pression (KRT18) than that on WI-38 (Fig. 1a, P<0.05,
Rank Sum Test). In this study, we used another hESC line,
namely BG01V, to confirm further the supportive roles of
hFF-1 on hESC growth. The morphologies of BG01V
grown on inactivated hFF-1 or WI-38 for 6 days were
compared. On day 6 of culture, the boundaries of BG01V
colonies cultured on WI-38 became non-distinctive and
differentiating colonies were noted. On the contrary, the
borders of the colonies growing on hFF-1 remained distinc-
tive with minimal differentiation (Fig. 1b). The colonies
were then graded into three classes based on the extent of
differentiation (shape, thickness and fragility) according to
previous studies (Heng et al. 2006; Richards et al. 2004;
Grade A: >90% undifferentiated; Grade B: 50–90% undif-
ferentiated; Grade C: <50% undifferentiated). The grading
was performed by two blinded observers: significantly more
colonies were graded as “A” on hFF-1 (51.7%) when com-
pared with WI-38 (7.78%), and the number of colonies
graded as “C” on hFF-1 (5%) was significantly lower than
that on WI-38 (33.3%). Immunofluorescent staining of
BG01V cultured on hFF-1 and WI-38 showed overall di-
minished intensities of pluripotent markers (NANOG,
OCT4, TRA-1-60, TRA-1-81 and SSEA-4) but an en-
hanced intensity of the early differentiation marker,
KRT18, in BG01V grown on WI-38 (Fig. 1c). We then
compared the mRNA expressions of the pluripotent
(NANOG, OCT4) and early differentiation (KRT8, KRT18)
markers in these cells; we found that KRT8 and KRT18 were
significantly higher in BG01V grown on WI-38 when com-
pared with those growing on hFF-1 (Fig. 1d; P<0.01, Rank
Sum Test), although no significant difference was found in
the pluripotent markers. The data further confirmed that
hFF-1 supported the undifferentiated growth of hESCs.
Differential gene expression in hFF-1 and WI-38
To improve our understanding of the way that feeder cells
support the pluripotency of hESCs, we used microarray
analysis to compare the gene expression pattern between
three independent samples of the supportive hFF-1 and the
non-supportive WI-38. Principal component analysis indi-
cated that the hFF-1 samples were separated from the WI-38
samples (Fig. 2a). In the unsupervised cluster analysis,
clustering of the hFF-1 samples from the WI-38 samples
was found (Fig. 2b). A total of 445 differentially up-
regulated genes (fold change >2; P<0.05) in the hFF-1 cells
was identified (Suppl. Table S1).
Among the genes differentially up-regulated (total 445)
in hFF-1 cells, gene ontology analysis showed that 93
(20.9%) belonged to the extracellular region and 69
Fig. 1 a–c Relative mRNA levels of NANOG, OCT4 and KRT18 of
H9 cultured on hFF-1 or WI-38 feeder layers (n04). d, e Representative
images of BG01V cultured on hFF-1 or WI-38 for 6 days. Bars 5 μm.
f–k Immunofluorescent staining of pluripotent markers (NANOG,
OCT4, TRA-1-60, TRA-1-81, SSEA4) and early differentiation mark-
er (KRT18) in BG01V cultured on hFF-1 and WI-38 (F fluorescence,
M merged images of fluorescence and propidium iodide). Bars 5 μm.
l–o Relative mRNA levels of the early differentiation markers (KRT8,
n07; KRT18, n09) and pluripotent markers (NANOG, n05; OCT4, n09)
in BG01V cultured on hFF-1 and WI-38. *P<0.05, **P<0.01
292 Cell Tissue Res (2012) 350:289–303
Cell Tissue Res (2012) 350:289–303 293
(15.5%) were involved in the regulation of transcription
activity (Suppl. Table S2). These genes were potential ben-
eficial factors for the maintenance of hESCs. In this study,
nine genes were selected for validation by qPCR. They were
selected based on the finding that they were for extracellular
matrix (ECM) proteins, interacting partners of ECM pro-
teins, molecules that were related to cell adhesion, or mol-
ecules interacting with pathways reported to be important in
the regulation of hESC pluripotency. Except for
thrombospondin-1 (THBS1), the expression of the other
eight genes including TGFA, fibulin-1 (FBLN1), nidogen-1
(NID1), chemokine (C-X-C motif) ligand-12 (CXCL12),
sulfatase-1 and −2 (SULF1 and SULF2), FGF2 and micro-
fibrillar associated protein-5 (MFAP5) were significantly
higher in the hFF-1 cells when compared with those in the
WI-38 cells (Fig. 3a, P<0.05, t-test).
TGFA was chosen for further validation because of its
reported action on mouse ESC (mESCs; Heo et al. 2008).
We first compared tgfa expression in two mouse fibroblast
cell lines, namely STO and NIH/3T3; the former was sup-
portive (Park et al. 2003, 2004), whereas the latter was non-
supportive (Wang et al. 2005) to hESC culture. The results
showed that the tgfamRNA level was significantly higher in
the supportive STO cells when compared with the non-
supportive NIH/3T3 cells (Fig. 3b, P<0.05, t-test). As both
human and mouse supportive feeder cells expressed higher
levels of TGFA, we postulated that it was involved in main-
taining the undifferentiated growth of hESC.
Knock-down or protein neutralization of TGFα in hFF-1
reduced H9 attachment and pluripotent marker gene
expressions
In the present study, we sought to study the biological role
of TGFα on the maintenance of hESC. Cell attachment is
important for the propagation and maintenance of hESC
culture. In this section, the effects of the knockdown of
TGFA expression by si-RNA or protein neutralization by
antibody against TGFα on H9 were examined. The attach-
ment of H9 was investigated by comparing the number of
H9 fragments attached to feeder layers with or without
treatments at 24 h after seeding. The attachment rates of
H9 fragments cultured on the hFF-1 feeder layer pre-treated
with TGFA si-RNA (100 nM) or TGFα antibody (0.8 ng/ml)
were found to be significantly lower when compared with
those of controls (Fig. 4a, P<0.05, Rank Sum Test).
H9 cultured on an hFF-1 feeder layer pre-treated with
TGFA si-RNA (100 nM) or TGFα antibody (0.8 ng/ml)
were found significantly to reduce the expression levels of
NANOG and OCT4 when compared to their respective con-
trols. On the other hand, the expression level of KRT18 was
significantly elevated in the TGFA si-RNA treatment group
(Fig. 4b, c, P<0.05, Rank Sum Test) but not after antibody
treatment.
TGFα rescued the maintenance of hESC culture and its
pluripotency under non-supportive conditions
Our results demonstrated that TGFα knockdown or pro-
tein neutralization in hFF-1 suppressed the attachment
rates and pluripotent marker gene expression in H9.
Next, we sought to investigate the effects of recombi-
nant TGFα supplementation on the growth of H9. H9
was grown in WI-38 CM with (wCMt) or without
(wCM) the supplementation of recombinant TGFα
(100 ng/ml) and compared with hFF-1 CM (hCM). As
expected, the attachment rate of H9 fragments was
significantly higher in hCM when compared with
wCM. The expression levels of pluripotent markers
Fig. 2 a Principal component analysis diagram of the microarray data
to examine the differences in the overall gene expression profiles of
hFF-1 (n03, red dots) and WI-38 (n03, blue dots). b Tree diagram of
unsupervised cluster analysis of the microarray data on three indepen-
dent samples of hFF-1 (a–c) and WI-38 (a–c). Red regions Highly
expressed genes. Green/brown regions Genes expressed at a lower
level
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NANOG and OCT4 were significantly lower, whereas
the expression of the differentiation gene KRT18 was
significantly higher in H9 cultured in wCM. The supplemen-
tation of TGFα to wCM (wCMt) was found to restore the
attachment rate and the expression levels of NANOG and
OCT4 in H9 to that in hCM. The expression of KRT18 in
H9 cultured in wCMt was also shown to be significantly
down-regulated (Fig. 5a, b, P<0.05, Rank Sum Test).
Fig. 3 a–i Quantitative
polymerase chain reaction
analysis for the validation of
selected gene expression
between hFF-1 (n010) and
WI-38 (n06). j Relative mRNA
levels of transforming growth
factor alpha (Tgfa) in mouse
feeder cells, namely STO and
NIH/3T3 (n05). *P<0.05
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To investigate whether TGFα supported the pluripo-
tency of hESC, H9 cultured in hCM, wCM, or wCMt
were subjected to in vitro differentiation by the forma-
tion of EB. We found that suspended EB with similar
sizes were formed on Day 4 among these three groups
(data not shown). The EBs were subjected to attachment
growth until Day 8. All the EB attached successfully
onto the culture plate. However, EBs of wCM (wCM-
EB) were found to have fewer outgrowths than those of
hCM (hCM-EB; Suppl. Fig. 2). Interestingly, EBs of the
wCMt groups (wCMt-EB) spread out on the culture
plate and retained a similar morphology to that of
hCM-EB (Suppl. Fig. 2). The mRNA expression of
the three germ layer markers in EB (mesoderm: REN
and T; ectoderm: NEFH; endoderm: AMY2A) were ana-
lyzed. Surprisingly, all three germ layer markers were
Fig. 4 a, b Relative attachment
rates of H9 after seeding on
hFF-1 transfected with scram-
ble small interfering RNA
(si-RNA) or TGFA si-RNA or
on hFF-1 pre-treated with goat
IgG or antibody against TGFα
(n04). c–e Relative mRNA lev-
els of NANOG, OCT4 and
KRT18 in H9 cultured on hFF-1
transfected with scramble
si-RNA or TGFA si-RNA (n04).
f–h Relative mRNA levels of
NANOG, OCT4 and KRT18 in
H9 cultured on hFF-1 pre-
treated with goat IgG or anti-
body against TGFα (n04).
*P<0.05)
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absent in wCM-EB, whereas the expression levels of plurip-
otent markers (NANOG and OCT4) and early-differentiation
marker (KRT18) were found to be much higher in wCM-EB
when compared with those in hCM-EB. On the contrary, all
the germ layer markers were detected in wCMt-EB. In addi-
tion, the expression levels of the pluripotent markers and early
differentiation marker in wCMt-EB were suppressed when
compared with those in wCM-EB (Fig. 5c). The findings
demonstrated that TGFα helped in the maintenance of hESC
and retained its pluripotency in non-conditioned medium.
TGFα activated the p44/42 MAPK but not the PI3K/Akt
pathway of hESCs
After we had confirmed the biological role of TGFα in the
maintenance of pluripotency of hESC, we studied the sig-
naling pathways induced by TGFα in hESC. H9 cells were
cultured in a feeder-free system without bFGF for 24 h
before treatment with 100 ng/ml recombinant human TGFα
for 0, 10, 30, or 60 min. TGFα activated the MAPK path-
way, as demonstrated, by a significantly higher expression
Fig. 5 a Relative attachment
rates of H9 after cultured in
hFF-1 conditioned medium
(hCM), WI-38 CM (wCM), or
WI-38 CM supplemented with
TGFα (wCMt), n05. b–d Rela-
tive mRNA levels of NANOG,
OCT4 and KRT18 of H9 cul-
tured in hCM, wCM, or wCMt
(n04). e, f Relative mRNA lev-
els of three germ layer markers
(mesoderm: REN and T; ecto-
derm: NEFH; endoderm:
AMY2A), pluripotent markers
(NANOG, OCT4) and early dif-
ferentiation marker (KRT18) in
embryoid body formed from
differentiation of H9 cultured in
hCM (hCM-EB), wCM (wCM-
EB), or wCMt (wCMt-EB)
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of phosphorylated p44/42 after the 10- and 60-min treat-
ments (Fig. 6a, P<0.05). The stimulatory action of TGFα on
phosphorylated p44/42 was suppressed by a mitogen-
activated protein kinase kinase (MEK) inhibitor, U0126.
No additive effect on the stimulation of the MAPK pathway
was found when H9 was treated with both bFGF and TGFα
(Fig. 6b). However, TGFα treatment did not activate the
phosphatidylinositol-3-kinase (PI3K)/AKT pathway in
hESCs as the levels of phosphotyrosine (Fig. 6c) and phos-
phorylated AKT (Fig. 6d, e) were not affected by TGFα
treatments.
TGFα increased the expression of pluripotent markers
NANOG and SSEA-3 in hESCs
The biological role of TGFα on the maintenance of hESC
was then studied. First, we investigated the functional role
of TGFα on the maintenance of undifferentiated growth of
hESC. After a 24-h treatment, TGFα (100 ng/ml) signifi-
cantly increased the protein expression of the pluripotent
marker, NANOG, when compared with the control (Fig. 7a,
P<0.05). Flow cytometric analysis also showed that TGFα
increased the percentage of cells expressing the surface
pluripotent marker, SSEA-3 (Fig. 7b).
TGFα did not affect proliferation of hESCs
The effect of TGFα on the proliferation of H9 was then
studied. However, our findings demonstrated that TGFα
had no effect on the protein expression level of a cell
proliferation marker, PCNA, as shown by using Western
blotting analysis (Fig. 7c). In addition, flow cytometric
analysis revealed that treatment of TGFα had no effect on
BrdU incorporation (Fig. 7d). The results implied that H9
cell proliferation was not affected by TGFα treatment.
Discussion
Human ESCs are commonly derived and propagated on
inactivated human or mouse feeder cells by using commer-
cially available knockout cell culture medium containing
bFGF. Current researches into hESC culture have concen-
trated on the development of defined culture conditions
without the use of feeder cells (Li et al. 2005; Ludwig et
al. 2006). Feeder cells have been suggested to provide ECM
molecules and soluble factors to maintain the pluripotency
of hESCs in culture (Assou et al. 2007). The combined use
of noggin, an MEF-expressing factor and bFGF can main-
tain the pluripotent growth of hESCs under feeder-free con-
ditions (Wang et al. 2005). However, hESC culture with the
defined medium still requires xenogenic matrigel that might
contain undefined contaminants (Curry 2009). Further
searches for the optimal hESC culture condition are needed.
The gene expression patterns of growth factors between
supportive human and mouse feeder cells are different.
Human but not mouse, feeder cells secrete bFGF
(Eiselleova et al. 2008). On the other hand, the latter
secrete more activin A than the former (Eiselleova et al.
2008). Thus, mouse and human feeder cells might sup-
port hESC growth via different pathways. By using
another hESC line, BG01V, we have further confirmed
the non-supportive role of WI-38 (Dravid et al. 2005;
Richards et al. 2003) on maintaining the undifferentiated
growth of hESC as demonstrated by higher early differ-
entiation marker expression in these cells. The lack of
effect on the expression of NANOG and OCT4 in BG01V
cultured on WI-38 might be attributable to the abnormal
karyotyping, which confers higher resistance to differentiation
(Zeng et al. 2004). Based on this rationale, H9 with a normal
karyotype has been used for subsequent functional assays in
this study. To improve our understanding of the way that
feeder cells support pluripotency of hESCs, we have used a
genomic approach to compare the gene expression pattern
between the supportive hFF-1 and the non-supportive WI-38
feeder cells. Previous studies have used the transcriptomic
approach (Kueh et al. 2006; Villa-Diaz et al. 2009) and pro-
teomic approach (Chin et al. 2007; Prowse et al. 2007, 2005)
to compare the gene expression patterns between supportive
and non-supportive feeder cells. In agreement with a similar
study involving the use of the serial analysis of gene expres-
sion (SAGE; Kueh et al. 2006) to compare the gene expres-
sion patterns between supportive human fetal skin fibroblasts
and non-supportive human embryonic lung fibroblasts, sever-
al genes including ECM components such as fibronectin,
sulfatase-1 and collagenα-1 and growth factors such as bFGF
and TGFα have also been found to be highly expressed in
supportive hFF-1 in the present study. Coincidentally, high
levels of fibronectin and collagen α-1 have been detected in
hFF-conditioned media (Prowse et al. 2007).
Gene ontology analysis of the transcriptomic data sug-
gests that many of the genes differentially up-regulated in
the supportive hFF-1 cells belong to the extracellular region
or are involved in the regulation of transcription. Therefore,
genes belonging to these groups have been selected for
validation. Among the validated genes, bFGF is well-
known for hESC self-renewal (Greber et al. 2007).
Nidogen-1 is an ECM protein that promotes hESC assembly
Fig. 6 a, b Effects of TGFα on the relative expression levels of
phosphorylated p44/42 in H9 after treated with (a) TGFA for 10, 30, or
60 mins (n05; ctrl control) and (b) basic fibroblast growth factor
(bFGF), TGFα and/or U0126 (n05). c Relative level of phosphotyr-
osine in H9 after TGFα treatment (n07). d, e Relative level of phos-
phorylated Akt at Thr308 and Ser473 in H9 after TGFA treatment
(n06). Statistical analysis was performed by one way analysis of
variance. *P<0.05
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(Evseenko et al. 2009). CXCL12 enhances the survival of
mESCs (Guo et al. 2005). TGFα is involved in cell prolif-
eration and the maintenance of pluripotency in mESCs (Heo
et al. 2008). However, the role of TGFα on hESC culture
was previously unknown. Therefore, this study has focused
on the functions of TGFα on hESCs.
The negative effects of TGFα knockdown and antibody
neutralization on H9 suggest a critical role of TGFα in
maintaining the undifferentiated growth of hESC. Most
importantly, the supplementation of TGFα to non-
supportive WI-38 CM partially rescues the pluripotent state
of H9, as shown by the increased levels of pluripotent
marker expression and the presence of marker expression
for the three germ layers upon in vitro differentiation. Added
together, our findings suggest that TGFα is involved in
maintaining the self-renewal and pluripotency of hESCs.
TGFα is a member of the epidermal growth factor (EGF)
family. It binds to the epidermal growth factor receptor
(EGFR) and triggers multiple downstream signaling path-
ways that are important in cell proliferation and survival
(Ferrer et al. 1996; Jorissen et al. 2003; Prenzel et al. 2000;
Santa-Olalla and Covarrubias 1995; Tang et al. 1997).
TGFα has been reported to be able to activate the MAPK
signaling pathway in cancer cells (Sawhney et al. 2004;
Fig. 7 a, b Effect of TGFα on
the expression of the
pluripotent marker, NANOG,
by Western blotting analysis
(n05) and the percentage of
cells expressing the pluripotent
marker, SSEA-3, by flow
cytometry analysis (n07), re-
spectively. c, d Effect of TGFα
on the relative expression levels
of proliferation markers, name-
ly proliferating cell nuclear an-
tigen (PCNA) protein by
Western blotting analysis (n04)
and BrdU incorporation by flow
cytometric analysis (n05).
*P<0.05)
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Zheng et al. 2008). Interestingly, TGFα also activates the
MAPK, PI3-K/AKT and Notch signaling pathways in
mESCs (Heo et al. 2008). However, the effect of TGFα on
hESC growth is unclear.
Our data demonstrate the activation of the p44/42 MAPK
pathway by TGFα. The effect is initiated rapidly within
10 min after TGFα treatment. The observation is in agree-
ment with the finding that TGFα stimulates the MAPK
cascade in mESCs (Heo et al. 2008). Since bFGF has been
reported to stimulate the MAPK pathway through FGF
receptors (Eiselleova et al. 2009), we have tested whether
bFGF has an additive effect with TGFα on MAPK pathway
activation. However, no additive effect has been found when
H9 is treated with both bFGF and TGFα, suggesting that the
treatment with TGFα might have activated the highest level
of p44/42 MAPKs.
In the present study, the knockdown of TGFA expression
or neutralization of TGFα leads to lower attachment rates of
H9 fragments. Previous studies have demonstrated that
TGFα activates the MAPK pathway leading to the increased
expression of integrin α2 for cellular adhesion in colon
cancer cells (Sawhney et al. 2004). Interestingly, the exog-
enous FGF-2-activated MAPK signaling pathway in hESC
is also involved in increasing hESC attachment and cloning
efficiency (Eiselleova et al. 2009). Our data on TGFα-
induced MAPK signaling and cell attachment suggest that
TGFα has a similar function to FGF-2 in maintaining the
undifferentiated growth of hESCs. In addition, under feeder-
free culture conditions, TGFα treatment increases the
expression of pluripotent markers, NANOG and SSEA-
3. NANOG is involved in maintaining the self-renewal
of ES cells (Chambers and Smith 2004). The overex-
pression of NANOG might maintain the self-renewal of
mESCs in the absence of LIF (Mitsui et al. 2003). Our
findings suggested that TGFα is involved in maintain-
ing the self-renewal of hESCs. The substitution of bFGF
with TGFα for the long-term culture of undifferentiated
hESC needs further investigation.
Our data have shown that the actions of TGFα on hESCs
are different from their actions on mESC. First, TGFα does
not activate the PI3-K/AKT pathway in hESCs. Second, it
has no effect on hESC proliferation. TGFα stimulates the
growth of glioma cells through the phosphorylation of
ERK1/2 (Zheng et al. 2008). TGFα can also reduce the
apoptotic rate induced by tumor necrosis factor-α (TNFα)
in human keratinocytes (Reinartz et al. 1996). In mESs,
TGFα increases the cell proliferation rate and promotes
DNA synthesis through the stimulation of the MAPK, PI3-
K/Akt and Notch signaling pathways (Heo et al. 2008). In
addition, TGFα inhibits apoptosis in mESCs (Heo et al.
2008), whereas increased apoptosis has been found in
TGFα-deficient mouse blastocysts (Brison and Schultz
1998). However, our data demonstrate no proliferative effect
of TGFα on the growth of hESC. This discrepancy of TGFα
effects on mESC and hESC might be explained in part by
the finding that the activation of the MAPK pathway main-
tains the pluripotency but does not increase the proliferation
rate of hESCs (Li et al. 2007).
In conclusion, TGFα is expressed at a higher level in the
supportive human and mouse feeder cells, hFF-1 and STO.
Blockage of TGFα function leads to lower attachment rates
and pluripotent marker gene expression. On the other hand,
the supplementation of TGFα in a non-supportive condi-
tioned medium can maintain the pluripotent gene expres-
sion, attachment rates and pluripotency of hESC. TGFα has
been found to activate the p44/42 MAPKs pathway and to
enhance the expression of pluripotent markers but not the
proliferation of H9. Further investigations into the roles of
other differentially expressed genes found in this study are
undergoing.
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